Gene Therapy — NEET Importance

NEET Importance Analysis

Gene therapy is a topic of significant importance for the NEET UG examination, primarily falling under the 'Biotechnology and its Applications' unit. Its relevance stems from being a cutting-edge field with direct implications for human health and disease treatment, making it a high-yield area for conceptual questions. Historically, NEET questions on gene therapy frequently test fundamental understanding, specific examples, and the underlying mechanisms.

Common question types include:

1
Direct Recall: — Questions about the definition of gene therapy, its purpose, or the types of cells targeted.
2
Specific Examples: — ADA deficiency (SCID) is a recurring favorite. Aspirants must know the disease, the enzyme deficiency, and the gene therapy approach (ex vivo, retroviral vector, target cells).
3
Vector Characteristics: — Understanding the properties, advantages, and disadvantages of different viral vectors (retroviruses, adenoviruses, AAVs) is crucial. Questions might compare their integration capabilities, cell tropism (dividing vs. non-dividing cells), and immunogenicity.
4
Conceptual Understanding: — Differentiating between ex vivo and in vivo approaches, and more importantly, between somatic and germline gene therapy, along with their ethical implications.
5
Risks and Challenges: — Awareness of potential issues like immune response, insertional mutagenesis, and off-target effects.

The topic's weightage is moderate to high, with at least one to two questions appearing in recent years, often carrying 4 marks each. Given its foundational role in biotechnology applications and its ethical dimensions, a thorough understanding is essential for securing marks in this section.

Vyyuha Exam Radar — PYQ Pattern

An analysis of previous year NEET (and AIPMT) questions on Gene Therapy reveals consistent patterns, indicating specific areas of focus for the examiners.

1
ADA-SCID Dominance: — Questions related to Severe Combined Immunodeficiency (SCID) due to Adenosine Deaminase (ADA) deficiency are overwhelmingly common. These questions often probe the specific enzyme deficiency, the type of gene therapy used (ex vivo), the vector employed (retrovirus), and the target cells (lymphocytes/hematopoietic stem cells). This suggests that a deep understanding of this particular case study is non-negotiable.
2
Vector Characteristics: — There's a recurring emphasis on the properties of different viral vectors. Questions frequently ask about which vector integrates its DNA, which remains episomal, which infects dividing vs. non-dividing cells, and their relative immunogenicity. Retroviruses, Adenoviruses, and Adeno-Associated Viruses (AAVs) are the most frequently tested.
3
Conceptual Distinctions: — The difference between somatic and germline gene therapy, and their ethical implications, is a consistent theme. Questions often test whether students understand the heritable nature of germline therapy and why it's not currently practiced. Similarly, distinguishing between ex vivo and in vivo approaches is also tested.
4
Risks and Challenges: — While less frequent than the above, questions occasionally touch upon the general risks associated with gene therapy, such as immune responses to vectors or the potential for insertional mutagenesis.
5
Difficulty Distribution: — Most questions tend to be of medium difficulty, requiring a clear conceptual understanding rather than complex problem-solving. Easy questions might ask for the definition or the primary goal, while harder ones might involve comparing multiple vector properties or subtle ethical nuances.

Overall, the pattern indicates that a strong grasp of the foundational principles, the ADA-SCID example, and the characteristics of common vectors, along with the ethical framework, will adequately prepare aspirants for questions from this topic.